Axonics Inc
NASDAQ:AXNX
Axonics Inc
NASDAQ:AXNX
Price:
70.98
USD
0.75%
Market Closed
Market Cap:
$3.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Axonics Inc
NASDAQ:AXNX
|
US |
|
Lucisano Media Group SpA
MIL:LMG
|
IT |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
H
|
Hangzhou Flariant Co Ltd
SSE:605566
|
CN |
|
G-Tec Jainx Education Ltd
NSE:GTECJAINX
|
IN |
|
J
|
Jin Tong Ling Technology Group Co Ltd
SZSE:300091
|
CN |
|
B
|
BNP Paribas SA
XETRA:BNP
|
FR |
|
J
|
Jiachen Holding Group Ltd
HKEX:1937
|
CN |
|
Fidus Investment Corp
NASDAQ:FDUS
|
US |
|
GCL New Energy Holdings Ltd
HKEX:451
|
HK |
|
C
|
Clean Teq Water Ltd
ASX:CNQ
|
AU |
|
D Market Elektronik Hizmetler ve Ticaret AS
NASDAQ:HEPS
|
TR |
|
J
|
Jiangsu New Energy Development Co Ltd
SSE:603693
|
CN |
|
Tobii AB
STO:TOBII
|
SE |
|
Thryv Holdings Inc
NASDAQ:THRY
|
US |
|
Southern Cross Media Group Ltd
ASX:SXL
|
AU |
|
Savannah Resources Plc
LSE:SAV
|
UK |
|
IONQ Inc
NYSE:IONQ
|
US |
Multiples-Based Value
The Multiples-Based Value of one
AXNX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 70.98 USD,
Axonics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AXNX Multiples-Based Value
LOCKED
Multiples Across Competitors
AXNX Competitors Multiples
Axonics Inc Competitors
Axonics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Axonics Inc
NASDAQ:AXNX
|
3.6B USD | 8.4 | -641 | 623.1 | -454.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.7B USD | 4 | 27.2 | 15.6 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 16 | 56.3 | 42.6 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.1B USD | 5.1 | 39.2 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92.8B USD | 4.6 | 32 | 19 | 25.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.8 | 43.9 | 24.1 | 26.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.5 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.2B USD | 2 | 25.2 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.8B USD | 6.1 | 22.1 | 15.5 | 17.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
